Evaluation of Tumor Necrosis Factor inhibitor therapy in Susac syndrome

被引：0
|
作者：
Buelens, T.
Ossewaarde-van Norel, A.
Nubourgh, I.
Glibert, G.
Semeu, P. Kamgang
Caspers, L.
Postelmans, L.
Willermain, F.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2016年 / 94卷
关键词：
D O I：
10.1111/j.1755-3768.2016.0567
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The tumor necrosis factor-associated periodic syndrome, the brain, and tumor necrosis factor-A antagonists
    Wildemann, B.
    Rudofsky, G., Jr.
    Kress, B.
    Jarius, S.
    Konig, F.
    Schwenger, V.
    NEUROLOGY, 2007, 68 (20) : 1742 - 1744
  • [32] Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α Inhibitor
    Yoshida, Masataka
    Takazono, Takahiro
    Tashiro, Masato
    Saijo, Tomomi
    Morinaga, Yoshitomo
    Yamamoto, Kazuko
    Nakamura, Shigeki
    Imamura, Yoshifumi
    Miyazaki, Taiga
    Sawai, Toyomitsu
    Nishino, Tomoya
    Izumikawa, Koichi
    Yanagihara, Katsunori
    Mukae, Hiroshi
    Kohno, Shigeru
    INTERNAL MEDICINE, 2016, 55 (21) : 3211 - 3214
  • [33] Tumor necrosis factor, cancer and anticancer therapy
    Mocellin, S
    Rossi, CR
    Pilati, P
    Nitti, D
    CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (01) : 35 - 53
  • [34] Tumor necrosis factor antagonists in the therapy of psoriasis
    Moessner, Rotraut
    Schoen, Michael P.
    Reich, Kristian
    CLINICS IN DERMATOLOGY, 2008, 26 (05) : 486 - 502
  • [35] Tumor necrosis factor a inhibitor therapy and cancer risk in chronic immune-mediated diseases
    Haynes, Kevin
    Beukelman, Timothy
    Curtis, Jeffrey R.
    Newcomb, Craig
    Herrinton, Lisa J.
    Graham, David J.
    Solomon, Daniel H.
    Griffin, Marie R.
    Chen, Lang
    Liu, Liyan
    Saag, Kenneth G.
    Lewis, James D.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 48 - 58
  • [36] A Rare but Morbid Occurrence: Development of Glioblastoma Multiforme During Tumor Necrosis Factor Inhibitor Therapy
    Kraemer, Laura S.
    Humes, Ross J.
    Syed, Azfar S.
    Tritsch, Adam M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [37] Changes in Bone Metabolism in Patients with Rheumatoid Arthritis during Tumor Necrosis Factor Inhibitor Therapy
    Jankovic, Tanja
    Mikov, Momir
    Zvekic Svorcan, Jelena
    Minakovic, Ivana
    Mikov, Jelena
    Boskovic, Ksenija
    Mikic, Darko
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [38] Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis
    Low, Audrey S. L.
    Lunt, Mark
    Mercer, Louise K.
    Watson, Kath D.
    Dixon, William G.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (06) : 1337 - 1345
  • [39] Crohn disease complicated by IgA vasculitis during therapy with tumor necrosis factor-α inhibitor
    Hokama, Akira
    Sonosaki, Tetsu
    Zamami, Ryo
    Aoyama, Hajime
    Kinjo, Tetsu
    Fujita, Jiro
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (04): : 283 - 284
  • [40] Perioperative Management of Methotrexate and Tumor Necrosis Factor Inhibitor Combination Therapy in Rheumatoid Arthritis Patients
    Juo, Hsin-Hsuan
    Ng, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345